These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9754356)

  • 1. [Origin and progression of thyroid epithelial tumors: molecular and cellular mechanisms].
    Gire V; Wynford-Thomas D
    Arch Anat Cytol Pathol; 1998; 46(1-2):11-8. PubMed ID: 9754356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular basis of tumors arising in thyroid follicular cells].
    Wynford-Thomas D
    Ann Chir; 1999; 53(3):237-43. PubMed ID: 10339867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal aberrations in thyroid follicular-cell neoplasia: in the search of novel oncogenes and tumour suppressor genes.
    Zitzelsberger H; Thomas G; Unger K
    Mol Cell Endocrinol; 2010 May; 321(1):57-66. PubMed ID: 19961897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenes and antioncogenes involved in human thyroid carcinogenesis.
    Lazzereschi D; Mincione G; Coppa A; Ranieri A; Turco A; Baccheschi G; Pelicano S; Colletta G
    J Exp Clin Cancer Res; 1997 Sep; 16(3):325-32. PubMed ID: 9387909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pathogenesis of thyroid nodules and cancer.
    Moretti F; Nanni S; Pontecorvi A
    Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Dec; 14(4):517-39. PubMed ID: 11289733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of epithelial tumorigenesis: the thyroid model.
    Wynford-Thomas D
    Crit Rev Oncog; 1993; 4(1):1-23. PubMed ID: 8416149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic dysregulation in thyroid neoplasia.
    Kondo T; Asa SL; Ezzat S
    Endocrinol Metab Clin North Am; 2008 Jun; 37(2):389-400, ix. PubMed ID: 18502333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cellular oncogenes and antioncogenes in thyroid tumors].
    Abrosimov AIu
    Arkh Patol; 1997; 59(1):64-9. PubMed ID: 9139613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic mutations in thyroid carcinoma.
    Taccaliti A; Boscaro M
    Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R; Shiohara M; Koeffler HP; Fagin JA
    Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions.
    Pavelić K; Dedivitis RA; Kapitanović S; Cacev T; Guirado CR; Danić D; Radosević S; Brkić K; Pegan B; Krizanac S; Kusić Z; Spaventi S; Bura M
    Mutat Res; 2006 Jul; 599(1-2):45-57. PubMed ID: 16698048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular biology of thyroid neoplasms.
    Satta MA; Nanni S; Della Casa S; Pontecorvi A
    Rays; 2000; 25(2):151-61. PubMed ID: 11370534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cribriform-morular variant of papillary carcinoma: the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma. A case report with clinical and molecular genetic correlation.
    Ng SB; Sittampalam K; Goh YH; Eu KW
    Pathology; 2003 Feb; 35(1):42-6. PubMed ID: 12701683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Search for NTRK1 proto-oncogene rearrangements in human thyroid tumours originated after therapeutic radiation.
    Bounacer A; Schlumberger M; Wicker R; Du-Villard JA; Caillou B; Sarasin A; Suárez HG
    Br J Cancer; 2000 Jan; 82(2):308-14. PubMed ID: 10646882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of well-differentiated human thyroid carcinomas by cDNA arrays.
    Zhao J; Leonard C; Brunner E; Gemsenjäger E; Heitz PU; Odermatt B
    Int J Oncol; 2006 Nov; 29(5):1041-51. PubMed ID: 17016634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic susceptibility to cancer. ICRP publication 79. Approved by the Commission in May 1997. International Commission on Radiological Protection.
    Ann ICRP; 1998; 28(1-2):1-157. PubMed ID: 10406427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Differential gene expression signatures in well differentiated thyroid carcinomas].
    Heitz PU; Zhao J; Leonard-Meier Ch; Gemsenjäger E; Odermatt B; Brunner E
    Verh Dtsch Ges Pathol; 2003; 87():185-7. PubMed ID: 16888911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathogenesis of thyroid cancer: the significance of oncogenes, tumor suppressor genes, and genomic instability.
    Farid NR
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():1-12. PubMed ID: 8980991
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular evidence for the same clonal origin of multifocal papillary thyroid carcinomas.
    McCarthy RP; Wang M; Jones TD; Strate RW; Cheng L
    Clin Cancer Res; 2006 Apr; 12(8):2414-8. PubMed ID: 16638846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The C allele of the GNB3 C825T polymorphism of the G protein beta3-subunit is associated with an increased risk for the development of oncocytic thyroid tumours.
    Sheu SY; Handke S; Bröcker-Preuss M; Görges R; Frey UH; Ensinger C; Ofner D; Farid NR; Siffert W; Schmid KW
    J Pathol; 2007 Jan; 211(1):60-6. PubMed ID: 17136758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.